Literature DB >> 2553441

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels.

J Bormann1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553441     DOI: 10.1016/0014-2999(89)90385-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  60 in total

Review 1.  Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.

Authors:  Daniel C Mathews; Ioline D Henter; Carlos A Zarate
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

Review 2.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

3.  Trends in the pathophysiology and pharmacotherapy of spasticity.

Authors:  J Noth
Journal:  J Neurol       Date:  1991-06       Impact factor: 4.849

Review 4.  Neuroprotection in glaucoma: drug-based approaches.

Authors:  William Cheung; Li Guo; M Francesca Cordeiro
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

5.  Memantine protects rats treated with intrathecal methotrexate from developing spatial memory deficits.

Authors:  Peter D Cole; Veena Vijayanathan; Nafeeza F Ali; Mark E Wagshul; Eric J Tanenbaum; Jeremy Price; Vidhi Dalal; Maria E Gulinello
Journal:  Clin Cancer Res       Date:  2013-07-05       Impact factor: 12.531

Review 6.  Glutamate: its role in learning, memory, and the aging brain.

Authors:  W J McEntee; T H Crook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

Authors:  Angela M Floden; Shanshan Li; Colin K Combs
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

8.  Key binding interactions for memantine in the NMDA receptor.

Authors:  Walrati Limapichat; Wesley Y Yu; Emma Branigan; Henry A Lester; Dennis A Dougherty
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

9.  Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.

Authors:  J Kornhuber; M Weller
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.

Authors:  T Frankiewicz; B Potier; Z I Bashir; G L Collingridge; C G Parsons
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.